Larimar Therapeutics stock target raised to $14.89
An analyst price target for Larimar Therapeutics, Inc. was raised to $14.89 on a 12-month basis, according to the provided headline and FactSet reference data.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.